合成目标产物 Maxacalcitol 主要起始原料 Methyllithium And Propanoic Acid, 3-[(1S)-1-[(1S,3As,4E,7As)-4-[(2Z)-[(3S,5R)-3,5-Bis[[(1,1-Dimethylethyl)Dimethylsilyl]Oxy]-2-Methylenecyclohexylidene]Ethylidene]Octahydro-7A-Methyl-1H-Inden-1-Yl]Ethoxy]-, Ethyl Este
(文献来源)合成步骤主要原料 Methyllithium 和 Propanoic Acid, 3-[(1S)-1-[(1S,3As,4E,7As)-4-[(2Z)-[(3S,5R)-3,5-Bis[[(1,1-Dimethylethyl)Dimethylsilyl]Oxy]-2-Methylenecyclohexylidene]Ethylidene]Octahydro-7A-Methyl-1H-Inden-1-Yl]Ethoxy]-, Ethyl Este
专利号:US-2022267266-A1 优先权日:2019-07-09 标 题 :Improved, cost effective process for synthesis of vitamin d3 and its analogue calcifediol from ergosterol 发明人:DATLA ANUPAMA; NAGRE PRASHANT; TAMORE JAGDISH; PRABHU MANOJKUMAR SADANAND; KADAM SACHIN VASANT 权利人:FERMENTA BIOTECH LTD 摘要:Disclosed herein is an improved and efficient process for synthesis of vitamin D3 and its analogue Calcifediol from Ergosterol. Particularly, the present invention discloses the synthesis of key intermediate 3β-tert-Butyldimethylsilyloxy-22-hydroxy-23,24-bisnorchola-5,7-diene (5), and novel intermediate β-tert-Butyldimethylsilyloxy-22-iodo-23,24-bisnorchola-5,7-diene (9) by a simple and cost effective process. The industrially viable processes for preparation of said intermediate(s) results in providing provitamins with various side chains and the desired products in high yield.
专利号:US-9221753-B2 优先权日:2004-02-03 标题:Process for the synthesis of vitamin D compounds and intermediates for the synthesis of the compounds 发明人:KASHIWAGI HIROTAKA; ONO YOSHIYUKI 权利人:KASHIWAGI HIROTAKA; ONO YOSHIYUKI; CHUGAI PHARMACEUTICAL CO LTD 摘要:An object of the present invention is to provide a process for synthesizing a vitamin D compound by simple procedures at lower costs. n The present invention provides a process for preparing a vitamin D compound and an intermediate thereof, comprising the step of: (a) mixing a ketone or aldehyde, a Wittig reagent, and a base; or (b) mixing a ketone or aldehyde and a Wittig reagent, and then adding a base to the resulting mixture.
专利号:US-6399767-B1 优先权日:1996-09-03 标 题 :Intermediates for the synthesis of vitamin D and steroid derivatives and process for preparation thereof 发明人:HORNE DAVID A; KUBODERA NOBORU; SUZUKI HIROSHI; SHIMIZU HITOSHI 权利人:UNIV COLUMBIA; CHUGAI PHARMACEUTICAL CO LTD 摘要:A process for preparing a compound having structure (I) wherein n is an integer from 1-5; each of R 1 and R 2 independently is optionally substituted C 1 -C 6 alkyl; each of W and X is independently hydrogen or C 1 -C 6 alkyl; Y is O, S or NR 3 where R 3 is hydrogen, C 1 -C 6 alkyl or a protective group; and Z is a CD ring structure, a steroid structure, or a vitamin D structure, each of which optionally having structure (IV) wherein W, X, Y and Z are defined above, in the presence of a base, with a compound having structure (V) or (v′) wherein n, R 1 and R 2 are as defined above, and E is an eliminating group.
专利号:US-2007135394-A1 优先权日:2004-02-03 标题 :Process for the synthesis of vitamin d compounds and intermediates for the synthesis of the compounds
专利号:IL-93896-A 优先权日:1989-03-28 标 题:Medicinal preparations containing the history of vitamin D3 for the suppression of synthesis of the parathyroid hormone and its secretion
专利号:WO-2021005619-A1 优先权日:2019-07-09 标 题 :Improved, cost effective process for synthesis of vitamin d3 and its analogue calcifediol from ergosterol
1: Karakawa M, Komine M, Kishimoto M, Maki N, Matsumoto A, Sugai J, Ohtsuki M. Effects of maxacalcitol ointment on skin lesions in patients with psoriasis receiving treatment with adalimumab. J Dermatol. 2016 Nov;43(11):1354-1357. doi: 10.1111/1346-8138.13515. Epub 2016 Jul 23. doi: 10.2220/biomedres.37.199. doi: 10.5326/JAAHA-MS-6286. Epub 2016 Jun 3. e7-224.e15. doi: 10.1016/j.urology.2016.03.008. Epub 2016 Mar 23. doi: 10.1111/1346-8138.13064. Epub 2015 Aug 18. doi: 10.1111/ced.12680. Epub 2015 May 19. doi: 10.1111/1744-9987.12242. Epub 2014 Nov 3. doi: 10.1016/j.steroids.2014.07.005. Epub 2014 Jul 17. doi: 10.5414/CP202020. doi: 10.1016/j.jaad.2012.10.044. doi: 10.1038/labinvest.2012.107. Epub 2012 Aug 27. doi: 10.3109/09546634.2012.687087. Epub 2012 Jun 12. doi: 10.2340/00015555-1294. doi: 10.1684/ejd.2012.1640. doi: 10.2340/00015555-1060. doi: 10.1111/j.1744-9987.2009.00706.x. doi: 10.1016/j.bone.2009.07.013. Epub 2009 Jul 23. doi: 10.1111/j.1346-8138.2009.00623.x.
合成参考文献
参考文献:10.1074/jbc.274.30.20874 摘要:Abe H, Iehara N, Utsunomiya K, Kita T, Doi T. A vitamin D analog regulates mesangial cell smooth muscle phenotypes in a transforming growth factor-beta type II receptor-mediated manner. J Biol Chem. 1999 Jul 23;274(30):20874–8. doi: 10.1074/jbc.274.30.20874. 参考文献:10.2165/00128071-200203030-00003 摘要:Cather J, Menter A. Novel Therapies for Psoriasis. American Journal of Clinical Dermatology. 2002 Apr;3(3):159–73. doi: 10.2165/00128071-200203030-00003. 参考文献:10.1007/s00467-004-1478-0 摘要:Cunningham J. New Vitamin D analogues for osteodystrophy in chronic kidney disease. Pediatr Nephrol. 2004 Jul;19(7):705–8. doi: 10.1007/s00467-004-1478-0. 参考文献:10.1007/s11255-008-9346-7|10.1007/s11255-008-9389-9 摘要:Kovesdy CP, Kalantar-Zadeh K. Bone and mineral disorders in pre-dialysis CKD. International Urology and Nephrology. 2008 Mar 27;40(2):427–40. doi: 10.1007/s11255-008-9346-7. 参考文献:10.1007/s11655-015-2293-0 摘要:Liu H, Sun W, Gu L, Tu Y, Yu B, Hu H. Huaiqihuang Granules (槐杞黄颗粒) reduce proteinuria by enhancing nephrin expression and regulating necrosis factor κB signaling pathway in adriamycin-induced nephropathy. Chinese Journal of Integrative Medicine. 2015 Oct 10;23(4):279–87. doi: 10.1007/s11655-015-2293-0.